AzTrials
AzTrials

Severe Traumatic Brain InjuryCSS-VAPNCT04323150

The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia.

A study testing Closed suction systems and Conventional suction system in people with Severe Traumatic Brain Injury and Pancreatic Diseases, run by Northern State Medical University at 1 site in Russia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators are suggesting that closed suction systems may reduce the risk of the ventilator - associated pneumoniae (VAP) and the contamination of the closest unanimated surfaces. In 2011 David et al. have shown that closed suction systems might reduce the incidence of the late VAP. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Closed suction systems and Conventional suction system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteRussia
Study dates
1 Feb 2018to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • invasive mechanical ventilation beyond 48 hours

Who cannot join

  • hospital - acquired pneumonia
  • community - acquired pneumoniae
  • BMI > 35 kg/cm2
  • pregnancy
  • tracheostomy

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Severodvinsk City Clinical Emergency Hospital # 2"

    Severodvinsk, 164522

Other trials in Russia

About this study

Official title: The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia, Respiratory-associated Microbiome and Contamination of Inanimate Surfaces: a Pilot Study.

The investigators are suggesting that closed suction systems may reduce the risk of the ventilator - associated pneumoniae (VAP) and the contamination of the closest unanimated surfaces. In 2011 David et al. have shown that closed suction systems might reduce the incidence of the late VAP. Research team is thinking that preventive bundle with closed suction systems can prevent to onset of the VAP. All enrolled patients is randomizing into two groups: control group - conventional suctioning and research group - suctioning with closed suction system.

Being tested
Closed suction systems, Conventional suction system
Medical subject headings
Brain Injuries, Traumatic, Pancreatic Diseases, Accidental Injuries, Seizures, Encephalitis, Intraabdominal Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Closed suction systemsDevice

    Closed suction systems are using for prevention of the ventilator-associated pneumoniae

  • Conventional suction systemDevice

    The using of open (conventional) suctioning

Study groups in NCT04323150
Study groupRoleWhat they receive
Closed suction systemsExperimentalNot described
Receives: Device: Closed suction systems
Open (conventional) suctionOthercontrol group
Receives: Device: Conventional suction system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of the ventilator - associated pneumoniae (VAP)

    Assessment of CPIS, if CPIS equal or more 6 points VAP will be observed

    Measured: Change from Baseline CPIS at 96 hours

  2. Contamination of closet inanimate surfaces

    Microbiology researching samples from circuit of a respirator and a bed

    Measured: Change from Baseline Microbiology researching at 96 hours

Secondary outcomes (5)
  1. Organ dysfunction

    Patient examination with Sequential Organ Function Assessment (SOFA)

    Measured: Change from Baseline SOFA at 96 hours

  2. Mortality

    Mortality for 28 days of a hospitalization

    Measured: 28 days

  3. C - reactive protein

    Investigation of a Biomarker of the VAP

    Measured: Change from Baseline CRP researching at 96 hours

  4. Procalcitonin

    Investigation of a Biomarker of the VAP

    Measured: Change from Baseline CRP researching at 96 hours

  5. sTREM 1

    Investigation of a Biomarker of the VAP

    Measured: Change from Baseline CRP researching at 96 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2020
  2. Study start1 Feb 2018
  3. Primary completion31 Dec 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04323150
Sponsor's protocol ID
CSS-VAP-1
Acronym
CSS-VAP
Status last verified
Apr 2022
First submitted
21 Mar 2020
Last updated
8 Apr 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing Closed suction systems and Conventional suction system in people with Severe Traumatic Brain Injury and Pancreatic Diseases, run by Northern State Medical University at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of the ventilator - associated pneumoniae (VAP) (time frame: Change from Baseline CPIS at 96 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in